1. Chimeric antigen receptor T cell therapies for lymphoma;Brudno;Nat Rev Clin Oncol,2018
2. Guidance for industry: CGMP for phase 1 investigational drugs,2008
3. Cell therapy: cGMP facilities and manfacturing;Gee,2009
4. Guidance for FDA reviewers and sponsors: content and review of Chemistry, manufacturing, and Control (CMC) information for human somatic cell therapy investigational new drug applications (INDs),2008
5. Guidance for FDA reviewers and sponsors: content and review of Chemistry, manufacturing, and Control (CMC) information for human gene therapy investigational new drug applications (INDs),2004